Grafting an active TSP-1 fragment into cyclic disulfide-rich frameworks is a novel approach for the TSP-1 research area and in the current study we have produced promising peptide-based inhibitors for targeting a range of blood vessel overgrowth diseases such as tumour angiogenesis, atherosclerosis and retinal disease. The gene discussed is THBS1; the disease is neoplasm.